ab	autoantibody
AchR	acetylcholine receptor
AMPAR 1/2	α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor 1/2
ANNA	anti-neuronal nuclear antibodies
AQP4	aquaporin 4
ARHGAP26	RhoGTPase-activating protein 26
CARP VIII	carbonic anhydrase related proteins VIII
CASPR2	contactin-associated protein-like 2
CBA	cell-based assays
CNS	central nervous system
CRMP5	collapsin response-mediator protein 5
CSF	cerebrospinal fluid
CTCAE	Common Terminology Criteria for Adverse Events
CTLA-4	cytotoxic T-lymphocyte-associated protein 4
DPPX	dipeptidyl-peptidase-like protein 6
GABAAR	gamma-aminobutyric-acid A receptor
GABABR	gamma-aminobutyric-acid B receptor
GAD65	glutamic acid decarboxylase 65
GBS	Guillain-Barré
GFAP	glial fibrillary acidic protein
GluD2	glutamate receptor delta 2
GlyR	glycine receptor
Homer-3	Homer protein homolog 3
ICH	immunohistochemistry
ICI	immune checkpoint inhibitor
Ig	immunoglobulin
IgLON5	immunoglobulin LON5
IQR	interquartile range
irAE-n	neurological immune-related adverse events
irAEs	immune-related adverse events
ITPR-1	inositol 1,4,5-trisphosphate receptor 1
LGI1	leucine-rich glioma-inactivated 1
LRP4	lipoprotein receptor-related protein 4
MAG	myelin-associated glycoprotein
MG	myasthenia gravis
mGluR1	metabotropic glutamate receptor 1
mGluR5	metabotropic glutamate receptor 5
MOG	myelin oligodendrocyte glycoprotein
MRI	magnetic resonance imaging
MuSK	muscle-specific tyrosine kinase
NMDAR	N-methyl-D-aspartate receptor
No	number
NSCLC	non-small cell lung cancer
P/Q VGCC	P/Q-type voltage-gated calcium channel
PCA-1	purkinje cell cytoplasmic antibody 1
PD-1	programmed cell death protein 1
PD-L1	programmed death-ligand 1
PND	paraneoplastic neurological disorders
PNS	peripheral nervous system
RyR	ryanodine receptor
SOX1	SRY-related HMG-box 1
vs.	versus
Zic4	zinc finger 4